As per the TechSci Research report titled “Global Creatinine Assay Market – Industry Size, Share, Trends, Competition Forecast & Opportunities, 2028,” the Global Creatinine Assay Market reached a value of USD 360.12 Million in 2022. It is projected to grow at a Compound Annual Growth Rate (CAGR) of 6.6% during the forecast period from 2024 to 2028. The upward trajectory of renal disorders and the increasing demand for creatinine measurement reagents and kits, driven by the surge in chronic disorders affecting kidney function, stand out as key drivers for the creatinine market. The expansion of the population, coupled with the rising cases of renal disorders, government policies advocating renal health, and technological advancements, contribute significantly to the growth of the creatinine measurement market.
The demand for Creatinine Assay Kits Market is further propelled by the necessity for mycobacteria detection in urine and the mounting number of elderly individuals grappling with renal failure. Looking ahead, the global Creatinine Assay Kits Market is anticipated to thrive due to the high prevalence of chronic kidney disease (CKD) and diabetes, the burgeoning geriatric population, and increased research and development endeavors. Additionally, the introduction of exogenous marker elements, augmented government funding, and a substantial volume of clinical laboratory activities all play roles in augmenting the global Creatinine Assay Kits Market.
Serum creatinine tests find wide usage in clinical chemistry laboratories across the globe. The market’s growth is further spurred by favorable reimbursements and innovative technological designs crafted by manufacturers, including occlusive cuffs or implants linked to pumps. Nonetheless, amidst these pivotal drivers, certain constraints could impact the growth of this market.
Browse over 26 market data Figures spread through 91 Pages and an in-depth TOC on “Global Creatinine Assay Market.” – https://www.techsciresearch.com/report/creatinine-assay-market/4535.html
The substantial global prevalence of renal disorders is a primary factor propelling market growth. As per the American Kidney Fund’s estimations, kidney disorders ranked as the ninth leading cause of death in the U.S. It is projected that over 1 in 7 U.S. adults, approximately 35.5 million people or 14%, will encounter Chronic Kidney Disease (CKD) by 2023. Moreover, as indicated by the Global Burden of Disease (GBD) estimates, approximately 1.2 million deaths were attributed to cardiovascular disorders in 2015, with diminished glomerular filtration rate fueling cardiovascular disorders. This high prevalence has prompted companies and health organizations to invest in robust tools for measuring renal disorders.
The demand for creatinine measurement kits and reagents is also buoyed by the growing incidence of other chronic disorders impacting kidney function. For instance, diabetes and high blood pressure collectively account for nearly 44% and 29% of total kidney failure cases, respectively. The market’s growth is further bolstered by the expanding global geriatric population, which is more susceptible to renal disorders, supportive governmental regulations promoting renal health, and the advent of monitoring technologies. A promising technological advancement in this realm is the utilization of point-of-care creatinine measuring devices, offering a swift method while eliminating the necessity for skilled analytical personnel to conduct intricate monitoring techniques.
Moreover, to enhance market expansion, the National Kidney Disease Education Program’s laboratory working group collaborated with the European Federation of Clinical Chemistry, Laboratory Medicine & International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) to establish the Creatinine Standardization Program. This governmental initiative has curtailed interlaboratory variation in creatinine assay calibration, leading to enhanced accuracy in glomerular filtration rate estimation. Such initiatives aid healthcare professionals in detecting and addressing various renal diseases, thereby enhancing patient outcomes. Conversely, healthcare professionals are shifting preferences towards novel techniques, including the identification of renal dysfunction biomarkers, while the lack of predictive value remains a hindrance to the growth of the creatinine measurement market.
The Global Creatinine Assay Market is categorized by test type, product, sample, end user, regional distribution, and company. Based on test type, the Jaffe Kinetic Method is poised to dominate the global creatinine assay market. The Jaffe reaction serves as a colorimetric method widely adopted in clinical chemistry to measure creatinine levels in blood and urine using Jaffe’s Kinetic Test Kits. According to the National Kidney Foundation, chronic kidney disease (CKD) affects approximately 10% of the global population, resulting in millions of annual deaths.
The Jaffe’s Kinetic Test Kits segment commands a significant market share in the creatinine assay kits market and is anticipated to maintain a consistent trend throughout the forecast period. This is attributed to its status as the conventional method for creatinine measurement, the widespread availability of products, and the cost-effectiveness of these kits. The escalating prevalence of renal disorders and other chronic conditions influencing renal function, alongside advancements in biomedical research related to kidney disorders, are pivotal factors driving the growth of the Jaffe’s kinetic test kits segment.
In terms of end users, the hospital segment is projected to capture the largest market share during the forecast period, as hospitals cater to a larger patient base. Additionally, hospitals possess greater financial resources, enabling them to utilize more advanced kits and reagents, ultimately leading to more accurate results in creatinine tests. Conversely, diagnostic laboratories are anticipated to exhibit the highest growth rate during the forecast period.
Major companies operating in Global Creatinine Assay Market are:
- Abbott Laboratories
- Thermo Fisher Scientific
- Merck KGaA
- Quidel Corporation
- Cell Biolabs, Inc.
- Genway Biotech
- Randox Laboratories Ltd.
- ACON Laboratories
- Nova Biomedical
- Sysmex India Pvt. Ltd.
“The rising prevalence of renal and other chronic disorders, technological advancements in biomedical research related to kidney disorders, and increased research and development efforts are the primary driving factors in the creatinine assay kits market. Creatinine assay kits are used to measure creatinine levels in serum/plasma, urine, and other biological samples. The creatinine assay helps analyze protein metabolism in the body, with creatinine levels being influenced by factors such as changes in muscle mass, pregnancy, and cancer. Elevated creatinine levels in blood tests indicate poor kidney function. Specific creatinine assay kits are used to perform the creatinine test for various conditions like hypertension, diabetes, and cancers.
Market growth in this sector is primarily propelled by the growing incidence of renal disorders, the impact of other chronic disorders on renal function, increased awareness and adoption of preventive healthcare practices, favorable government initiatives promoting renal health, rapid growth in the elderly population, and advancements in biomedical research on kidney disorders. However, the limited utilization of creatinine assay kits in in vitro diagnostics (IVD) and the identification of novel biomarkers for renal dysfunction may pose challenges to market growth in the future.,” said Mr. Karan Chechi, Research Director with TechSci Research, a research-based management consulting firm.
“Global Creatinine Assay Market By Test Type (Jaffe Kinetic Method, Enzymatic Method), By Product (Reagents, Kits), By Sample (Blood/Serum, Urine), By End User (Hospitals, Diagnostic Laboratories), By Region, By Competition Forecast & Opportunities, 2018-2028F”, has evaluated the future growth potential of Global Creatinine Assay Market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Global Creatinine Assay Market.
Download Free Sample Report – https://www.techsciresearch.com/sample-report.aspx?cid=4535
Related Reports –
About TechSci Research:
TechSci Research is a research-based management consulting firm providing market research and advisory solutions to its customers worldwide, spanning a range of industries. TechSci Research’s core values are value, integrity and insight. Led by a team of dynamic industry experts, TechSci Research provides its customers with high value market research and advisory services that helps them identify new market opportunities, growth engines and innovative ways to capture the market share. As a result, TechSci’s client leads rather than follow market trends. Not bound by legacy, TechSci’s cutting-edge research model leverages its decades of research knowledge and increased use of technology as engines of innovation to deliver unique research value. Provided as an alternative to traditional market research, TechSci Research reports do not just deliver data and knowledge rather highlights the insights in a more usable and interactive format for its clients.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: sales@techsciresearch.com
Web: https://www.techsciresearch.com